GXMC
AZN icon

Global X Management Company’s AstraZeneca AZN Stock Holding History

Global X Management Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-683
Closed -$49K – 550
2014
Q3 		$49K Buy
+683
New +$50K ﹤0.01% 359

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Global X Management Company's AZN Position: Q4 2014 in Review

Global X Management Company sold out of AstraZeneca (AZN) in Q4 2014, closing a stake of 683 shares — an estimated $49K sold.

Global X Management Company first reported a position in AZN in Q3 2014 and held it in 1 quarter. The position peaked at $49K in Q3 2014. 403 funds tracked by Wall St. Rank hold AZN as of Q4 2014.

  • Global X Management Company reported no remaining AstraZeneca position as of Q4 2014 after selling out during the quarter.
  • Global X Management Company sold 683 AstraZeneca shares in Q4 2014, an estimated $49K.
  • Global X Management Company first reported a position in AstraZeneca in Q3 2014 and held it in 1 quarter.
  • Global X Management Company's AstraZeneca position peaked at $49K in Q3 2014.
  • 403 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2014.

Based on Global X Management Company's 13F filing for Q4 2014, filed 12 Feb 2015.